<p>A. The tumor images obtained 6(day 0) (top panel) and 32 days after the first treatment (day 32) (bottom panel). Mice were injected with 100 µl of D-luciferin K<sup>+</sup> (GoldBio) (150 mg/kg) by I.P. and tumor cells were visualized using IVIS Lumina XR (Caliper Life Science). B. The bioluminescent intensities of tumors at day 0 and day 32 after indicated treatments were plotted as a graph. C. The ratios of bioluminescent signals observed at day 0 and day 32. Error bars represent SD.</p
<p>(A) Representative bioluminescence images of mice intracardially injected with luciferase-express...
SOPF/SHO SCID mice (6–8 weeks-old) were injected subcutaneously with CLBL-1GFP+Luciferase+ cells usi...
<p>Gompertz growth curves were fitted to these data to illustrate the tumor growth. (<b>A</b>) MiaPa...
<p>After 11 days of tumor inoculation, tumors were touchable. Then mice were randomly regrouped (n =...
<p><b>(A)</b><i>In vivo</i> bioluminescence imaging of representative animals from each treatment gr...
<p>Tumor growth was slower in mice fed the KD than in mice fed the SD. (A) Representative animals fr...
<p>3a. Bioluminescence signal of PIK3CA promoter in PPF tumors. 3a1. Graphical representation of the...
<p>Tumors measured in two dimensions with calipers every 2 days prior to administration of treatment...
<p>(A) Schematic representation of the experimental design and timing of data and sample collection ...
<p>(A), Bioluminescent imaging of female mice treated with bicalutamide (50mg/kg) for 24 and 48 hour...
<p>A. MDA-MB-231 cells were exposed to cisplatin (in indicated concentrations) in the absence or pre...
<p><b>(A)</b><i>In vivo</i> bioluminescence of key metastatic regions 21 days after tumor cell inocu...
<p>Bioluminescent imaging of male mice treated with bicalutamide (50mg/kg) for 24 and 48 hours. (A),...
<p>Asterisk (*) denotes statistical significance of data obtained from mice treated with EGCG (Day 1...
<p>(A, B) BLI of the same mouse as shown in <a href="http://www.plosone.org/article/info:doi/10.1371...
<p>(A) Representative bioluminescence images of mice intracardially injected with luciferase-express...
SOPF/SHO SCID mice (6–8 weeks-old) were injected subcutaneously with CLBL-1GFP+Luciferase+ cells usi...
<p>Gompertz growth curves were fitted to these data to illustrate the tumor growth. (<b>A</b>) MiaPa...
<p>After 11 days of tumor inoculation, tumors were touchable. Then mice were randomly regrouped (n =...
<p><b>(A)</b><i>In vivo</i> bioluminescence imaging of representative animals from each treatment gr...
<p>Tumor growth was slower in mice fed the KD than in mice fed the SD. (A) Representative animals fr...
<p>3a. Bioluminescence signal of PIK3CA promoter in PPF tumors. 3a1. Graphical representation of the...
<p>Tumors measured in two dimensions with calipers every 2 days prior to administration of treatment...
<p>(A) Schematic representation of the experimental design and timing of data and sample collection ...
<p>(A), Bioluminescent imaging of female mice treated with bicalutamide (50mg/kg) for 24 and 48 hour...
<p>A. MDA-MB-231 cells were exposed to cisplatin (in indicated concentrations) in the absence or pre...
<p><b>(A)</b><i>In vivo</i> bioluminescence of key metastatic regions 21 days after tumor cell inocu...
<p>Bioluminescent imaging of male mice treated with bicalutamide (50mg/kg) for 24 and 48 hours. (A),...
<p>Asterisk (*) denotes statistical significance of data obtained from mice treated with EGCG (Day 1...
<p>(A, B) BLI of the same mouse as shown in <a href="http://www.plosone.org/article/info:doi/10.1371...
<p>(A) Representative bioluminescence images of mice intracardially injected with luciferase-express...
SOPF/SHO SCID mice (6–8 weeks-old) were injected subcutaneously with CLBL-1GFP+Luciferase+ cells usi...
<p>Gompertz growth curves were fitted to these data to illustrate the tumor growth. (<b>A</b>) MiaPa...